Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2791 Results
Secondary cancers following CAR T cell therapy are rare
3d illustration of a damaged and disintegrating cancer cell.

Image: iStock/vitanovski

Secondary cancers following CAR T cell therapy are rare

A new Penn Medicine analysis shows that the development of any type of second cancer is a rare occurrence, and some of the earliest patients have gone on to experience long-lasting remissions of a decade or more.

From Penn Medicine News

New Penn Medicine Nudge Unit pilots show simple questions can improve care
A patient being wheeled in the hospital flanked by two medical professionals.

Image: iStock/PeopleImages

New Penn Medicine Nudge Unit pilots show simple questions can improve care

Experts at the Penn Medicine Center for Addiction Medicine and Policy have seen success in treatment after posing one question: “Why not treat alcohol use the same way we’ve been treating opioid use?”

Frank Otto

A successful new experiment opens potential for future bridge-to-transplant approach
Human body with a rendering of liver in the foreground.

Image: iStock/Mohammed Haneefa Nizamudeen

A successful new experiment opens potential for future bridge-to-transplant approach

A team at Penn Medicine has achieved the first successful external liver perfusion using a porcine liver, raising hopes for a possible effective option to “bridge” critically ill patients to liver transplant.

From Penn Medicine News

Q&A with Interim President J. Larry Jameson
J. Larry Jameson at a podium during the MLK Day of Service.

Named Penn’s interim president this past December, J. Larry Jameson addresses and thanks volunteers gathered for the MLK Day of Service at Houston Hall on Jan. 15, 2024.

nocred

Q&A with Interim President J. Larry Jameson

Penn’s leader offers a glimpse into his background; his thoughts on academic freedom, shared governance, safety on campus; and his priorities for the semester ahead.

Penn Today Staff